Onderneming Willow Biosciences Inc Canadian Securities Exchange
Aandelen
CA97111B1076
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Research and Development
100,0
%
| 1 | 77,2 % | 1 | 100,0 % | +84,86% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 77,2 % | 1 | 100,0 % | +84,86% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chris Savile
CEO | Chief Executive Officer | - | 12-04-19 |
Travis Doupe
DFI | Director of Finance/CFO | - | 12-04-19 |
Trish Choudhary
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-19 |
Simon Hickling
PRN | Corporate Officer/Principal | - | - |
Sony Gill
SEC | Corporate Secretary | 48 | 12-04-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jim Lalonde
CHM | Chairman | 63 | 21-02-23 |
Donald Archibald
BRD | Director/Board Member | 63 | 12-04-19 |
Director/Board Member | 51 | 12-04-19 | |
Raffi Asadorian
BRD | Director/Board Member | 54 | 11-05-23 |
Chris Savile
CEO | Chief Executive Officer | - | 12-04-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 127 345 288 | 93 362 456 ( 73,31 %) | 0 | 73,31 % |
Bedrijfsgegevens
Willow Biosciences, Inc.
1201 5th Street South West Suite 202
T2R 0Y6, Calgary
+
http://www.willowbio.com![Adres Willow Biosciences Inc](https://cdn.zonebourse.com/static/address/57237536.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,97% | 94,74 mld. | |
-4,08% | 37,28 mld. | |
-13,26% | 32,68 mld. | |
+74,21% | 27,72 mld. | |
-11,58% | 16,19 mld. | |
-1,66% | 13,88 mld. | |
-11,67% | 11,58 mld. | |
+190,36% | 10,92 mld. | |
-52,61% | 9,54 mld. |